Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis

Published:2022-10-18 Issue:1 Volume:25 Page:1140-1148
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Gallagher Meghan E.¹,Chawla Anjulika¹,Brady Brenna L.²,Badawy Sherif M.³⁴^ORCID

Affiliation:

1. Bluebird bio, Somerville, MA, USA

2. Merative, Cambridge, MA, USA

3. Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

4. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Funder

bluebird bio

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2133824

Reference25 articles.

1. Therapeutic strategies for sickle cell disease: towards a multi-agent approach

2. Pathophysiology of Sickle Cell Disease

3. Sickle cell disease

4. Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease

5. Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States;PharmacoEconomics;2024-04-29

2. Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications;Anemia;2024-03-19

3. The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis;Scientific Reports;2024-02-01

4. Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease;Blood Advances;2023-12-29

5. Intravenous fluid therapy and hospital outcomes for vaso‐occlusive episodes in children, adolescents, and young adults with sickle cell disease;Pediatric Blood & Cancer;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3